Tags

Type your tag names separated by a space and hit enter

[Diagnostic criteria of diffuse Lewy body disease].
Nihon Rinsho. 2000 Oct; 58(10):2044-8.NR

Abstract

DLBD is also called Dementia with Lewy bodies(DLB) which was proposed by the consortium on DLB international workshop(CDLB) in 1995. CDLB criteria of clinical diagnosis contain progressive cognitive decline as a mandatory feature, and fluctuating cognition, recurrent visual hallucinations and parkinsonism as 3 core features. Supportive features include repeated falls, syncope, transient loss of consciousness, neuroleptic sensitivity, and systematized delusions. CDLB pathologic criteria include the presence of Lewy bodies as the only essential feature, and associated features included Lewy-related neurites, senile plaques, neurofibrillary tangles, and regional neuronal loss in the areas vulnerable to Parkinson's disease. Lewy bodies are counted and scored from 0 to 2 in 5 designated cortical areas. Total Lewy body score of 7-10 indicates DLBD.

Authors+Show Affiliations

Department of Neurology, Nihon University School of Medicine.

Pub Type(s)

English Abstract
Journal Article
Review

Language

jpn

PubMed ID

11068444

Citation

Mizutani, T. "[Diagnostic Criteria of Diffuse Lewy Body Disease]." Nihon Rinsho. Japanese Journal of Clinical Medicine, vol. 58, no. 10, 2000, pp. 2044-8.
Mizutani T. [Diagnostic criteria of diffuse Lewy body disease]. Nihon Rinsho. 2000;58(10):2044-8.
Mizutani, T. (2000). [Diagnostic criteria of diffuse Lewy body disease]. Nihon Rinsho. Japanese Journal of Clinical Medicine, 58(10), 2044-8.
Mizutani T. [Diagnostic Criteria of Diffuse Lewy Body Disease]. Nihon Rinsho. 2000;58(10):2044-8. PubMed PMID: 11068444.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Diagnostic criteria of diffuse Lewy body disease]. A1 - Mizutani,T, PY - 2000/11/9/pubmed PY - 2001/2/28/medline PY - 2000/11/9/entrez SP - 2044 EP - 8 JF - Nihon rinsho. Japanese journal of clinical medicine JO - Nihon Rinsho VL - 58 IS - 10 N2 - DLBD is also called Dementia with Lewy bodies(DLB) which was proposed by the consortium on DLB international workshop(CDLB) in 1995. CDLB criteria of clinical diagnosis contain progressive cognitive decline as a mandatory feature, and fluctuating cognition, recurrent visual hallucinations and parkinsonism as 3 core features. Supportive features include repeated falls, syncope, transient loss of consciousness, neuroleptic sensitivity, and systematized delusions. CDLB pathologic criteria include the presence of Lewy bodies as the only essential feature, and associated features included Lewy-related neurites, senile plaques, neurofibrillary tangles, and regional neuronal loss in the areas vulnerable to Parkinson's disease. Lewy bodies are counted and scored from 0 to 2 in 5 designated cortical areas. Total Lewy body score of 7-10 indicates DLBD. SN - 0047-1852 UR - https://www.unboundmedicine.com/medline/citation/11068444/[Diagnostic_criteria_of_diffuse_Lewy_body_disease]_ L2 - https://www.medicalonline.jp/meteo_linkout.php?issn=0047-1852&volume=58&issue=10&spage=2044 DB - PRIME DP - Unbound Medicine ER -